Dong Ji
机构：Peking University, Chinese PLA General Hospital, People's Liberation Army 411 Hospital · ORCID：0000-0001-8214-462X
发表论文 160 篇 · 总被引 3988 次 · h-index 28
代表论文
- acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study (2024 · Clinical Gastroenterology and Hepatology · 被引 17)
- Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis (2024 · Hepatology International · 被引 17)
- Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment (2024 · Frontiers in Cellular and Infection Microbiology · 被引 8)
- Biejia ruangan tablet alleviated liver fibrosis in murine models by hindering the crosstalk between hepatic stellate cells and M2-like macrophages through PDGF-AA/PI3K/AKT pathway (2025 · Journal of Ethnopharmacology · 被引 7)
- RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer (2025 · Signal Transduction and Targeted Therapy · 被引 6)
- Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury (2024 · iLiver · 被引 6)